BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20280326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20281029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20290325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20291028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20280312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20281105T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261023
DTEND;VALUE=DATE:20280205
DTSTAMP:20260127T204055Z
CREATED:20250715T190605Z
LAST-MODIFIED:20260127T204055Z
UID:10000218-1792742400-1833296400@oncodaily.com
SUMMARY:The ESMO Congress 2026
DESCRIPTION:The ESMO Congress 2026 will take place from 23–27 October in Madrid\, Spain\, bringing together oncology professionals from around the world. \nThis global event serves as a key platform for presenting groundbreaking research\, advancing clinical practice\, and shaping patient care in oncology. Attendees can expect new data releases\, interactive educational sessions\, networking opportunities\, and an innovative exhibition area. \nLed by Congress President Fabrice André\, along with Scientific Co-Chairs Yelena Janjigian and James Larkin\, and Educational Chair Nadia Harbeck\, the congress will cover the latest developments across all areas of cancer care. By joining ESMO 2026\, participants contribute to global progress in oncology while staying up to date with the most relevant clinical and research advancements. \nRead More Posts Featuring ESMO at OncoDaily.com.
URL:https://oncodaily.com/event/esmo-329848
LOCATION:Madrid\, Madrid\, Community of Madrid\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7216.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261111
DTEND;VALUE=DATE:20261113
DTSTAMP:20260127T203943Z
CREATED:20260127T203943Z
LAST-MODIFIED:20260127T203943Z
UID:10000635-1794355200-1794527999@oncodaily.com
SUMMARY:ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026: Barcelona
DESCRIPTION:The ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026: Barcelona is scheduled to take place in Barcelona\, Spain\, from November 11–12\, 2026. \nThis specialized educational program is co-chaired by Simon Ekman\, Lizza Hendriks\, and Natasha Leighl\, and focuses on providing oncologists with high-level training on the evolving diagnostic and therapeutic strategies for brain metastases originating from lung and breast malignancies. The course is designed to address the clinical challenges of managing central nervous system involvement\, highlighting the latest research\, systemic therapies\, and multidisciplinary approaches essential for optimizing patient outcomes in these complex cases. \nApplication.
URL:https://oncodaily.com/event/brain-metastases-448007
LOCATION:Barcelona\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-8.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261113
DTEND;VALUE=DATE:20261115
DTSTAMP:20260826T134459Z
CREATED:20260826T134459Z
LAST-MODIFIED:20260826T134459Z
UID:10000961-1794528000-1794700799@oncodaily.com
SUMMARY:The ESMO Advanced Course on Cholangiocarcinoma 2026
DESCRIPTION:The ESMO Advanced Course on Cholangiocarcinoma 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on November 13–14\, 2026\, in Barcelona\, Spain. \nThe course is designed to provide an advanced multidisciplinary update on the diagnosis and management of cholangiocarcinoma\, covering diagnostic challenges\, clinical and molecular differences between disease subtypes\, adjuvant and palliative treatment strategies\, surgery and other locoregional therapies\, immunotherapy\, and currently available and emerging targeted treatments for advanced disease. \nThe programme is aimed at oncology professionals seeking deeper practical knowledge of this complex malignancy and has been accredited with 11 ESMO-MORA Category 1 points.
URL:https://oncodaily.com/event/advanced-course-on-cholangiocarcinoma-574980
LOCATION:Barcelona\, Barcelona\, Catalonia\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-05_12_07-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261116
DTEND;VALUE=DATE:20261119
DTSTAMP:20251127T193815Z
CREATED:20251127T193756Z
LAST-MODIFIED:20251127T193815Z
UID:10000412-1794787200-1795046399@oncodaily.com
SUMMARY:ESMO AI and Digital Oncology Congress 2026
DESCRIPTION:The ESMO AI and Digital Oncology Congress 2026 will take place from November 16-18\, 2026\, in Berlin\, Germany. \nThis congress is designed as a central meeting point that facilitates the exchange of the latest research\, promotes ethical dialogue\, and highlights technological innovation in cancer care. \nIt brings together healthcare and digital health experts from around the world to foster collaboration\, inspire learning\, and empower oncology professionals to stay ahead in the rapidly evolving digital transformation of medicine. \nThe specific congress venue within Berlin is expected to be announced on the official European Society for Medical Oncology (ESMO) website closer to the event date.
URL:https://oncodaily.com/event/esmo-417477
LOCATION:Berlin\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ESMO-2.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261118T183000
DTEND;TZID=America/Halifax:20261118T183000
DTSTAMP:20260905T151650Z
CREATED:20260905T151650Z
LAST-MODIFIED:20260905T151650Z
UID:10000996-1795026600-1795026600@oncodaily.com
SUMMARY:ESMO Deep Dive: Are We Defeating Cervical Cancer?
DESCRIPTION:The ESMO Deep Dive: Gynaecological Cancers – Are We Defeating Cervical Cancer? 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on November 18\, 2026\, at 6:30 PM CET (9:30 PM AMT) as a live virtual webinar. \nThe session will review recent progress and remaining challenges in cervical cancer management\, including pembrolizumab combined with concurrent chemoradiation for locally advanced disease\, the role of immune checkpoint inhibitors in recurrent or metastatic cervical cancer\, and treatment options after progression on immunotherapy. \nThe expert discussion will examine how these developments are changing clinical practice and what questions remain as systemic treatment strategies continue to evolve. Participants attending the live session can earn 2 ESMO-MORA Category 1 points.
URL:https://oncodaily.com/event/esmo-deep-dive-581188
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-5-2026-07_13_26-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261125
DTEND;VALUE=DATE:20261127
DTSTAMP:20260903T202512Z
CREATED:20260903T202437Z
LAST-MODIFIED:20260903T202512Z
UID:10000992-1795564800-1795737599@oncodaily.com
SUMMARY:ESMO Advanced Course on Endocrine Sensitivity in HR+/HER2− Metastatic Breast Cancer 2026
DESCRIPTION:The ESMO Advanced Course on Defining Endocrine Sensitivity & Optimising Treatment Strategies in HR+/HER2− mBC Patients 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on November 25\, 2026\, in Barcelona\, Spain. \nThe course will focus on the increasingly complex management of hormone receptor-positive\, HER2-negative metastatic breast cancer\, particularly how clinicians define endocrine sensitivity and resistance and use these distinctions to guide treatment decisions. \nThe programme is designed to support evidence-based therapeutic selection and sequencing as treatment options for HR+/HER2− metastatic disease continue to expand\, with emphasis on integrating clinical and molecular information into individualized patient management.
URL:https://oncodaily.com/event/endocrine-sensitivity-580276
LOCATION:Barcelona\, Barcelona\, Catalonia\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-4-2026-12_22_08-AM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261204
DTEND;VALUE=DATE:20261207
DTSTAMP:20260105T000508Z
CREATED:20260105T000502Z
LAST-MODIFIED:20260105T000508Z
UID:10000552-1796342400-1796601599@oncodaily.com
SUMMARY:ESMO Asia Congress 2026
DESCRIPTION:The ESMO Asia Congress 2026 is the premier scientific platform in the Asia-Pacific region for oncology professionals\, scheduled for December 4-6\, 2026\, in Singapore. \nOrganized by the European Society for Medical Oncology (ESMO)\, this major international congress brings together global experts and regional leaders to present the latest research and clinical data across all major tumor types. \nThe technical program features high-level scientific symposia\, educational sessions on state-of-the-art treatments\, and a dedicated Young Oncologists track aimed at fostering the next generation of cancer researchers. The event emphasizes regional specificities in cancer management and promotes collaborative research to improve patient outcomes throughout Asia.
URL:https://oncodaily.com/event/esmo-asia-436785
LOCATION:Suntec Singapore Convention & Exhibition Centre\, 1 Raffles Boulevard Singapore\, Singapore\, 039593\, Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Asia-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261214
DTEND;VALUE=DATE:20261217
DTSTAMP:20251211T194040Z
CREATED:20251211T193956Z
LAST-MODIFIED:20251211T194040Z
UID:10000476-1797206400-1797465599@oncodaily.com
SUMMARY:ESMO Immuno-Oncology Congress 2026
DESCRIPTION:The ESMO Immuno-Oncology Congress 2026 is a premier international event hosted by the European Society for Medical Oncology (ESMO)\, scheduled for December 14–16\, 2026\, as an onsite event in London\, United Kingdom\, with an online option also available. \nThe congress serves as a critical platform for exchanging knowledge and fostering collaboration in immuno-oncology\, covering the entire spectrum of the field from basic science to translational research and clinical development. The meeting will feature the latest scientific advances\, offering researchers\, clinicians\, and other stakeholders excellent opportunities to interact\, share expertise\, and engage with the global community committed to advancing cancer care through innovation.
URL:https://oncodaily.com/event/immuno-oncology-426416
LOCATION:London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-IO-2026.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270113
DTEND;VALUE=DATE:20270115
DTSTAMP:20260905T150053Z
CREATED:20260905T150053Z
LAST-MODIFIED:20260905T150053Z
UID:10000995-1799798400-1799971199@oncodaily.com
SUMMARY:ESMO Preceptorship on Prostate Cancer 2027
DESCRIPTION:The ESMO Preceptorship on Prostate Cancer 2027\, organized by the European Society for Medical Oncology (ESMO)\, will take place on January 13–14\, 2027\, in Hong Kong SAR\, China. \nThe two-day educational course will provide a multidisciplinary update on the management of prostate cancer\, covering the disease continuum from diagnosis and risk assessment through localized and advanced disease. \nESMO prostate cancer preceptorships are structured around current standards of care\, multidisciplinary decision-making\, systemic and local treatment strategies\, emerging therapeutic targets\, and future perspectives\, combining expert lectures with practical clinical discussion. The meeting takes place immediately before the inaugural ESMO Genitourinary Cancers Asia 2027\, which begins in Hong Kong on January 15.
URL:https://oncodaily.com/event/preceptorship-on-prostate-cancer-581173
LOCATION:Hong Kong\, Hong Kong\, Hong Kong SAR\, China
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-5-2026-06_58_44-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270115
DTEND;VALUE=DATE:20270118
DTSTAMP:20260826T143152Z
CREATED:20260826T143152Z
LAST-MODIFIED:20260826T143152Z
UID:10000963-1799971200-1800230399@oncodaily.com
SUMMARY:The Inaugural ESMO Genitourinary Cancers Asia 2027
DESCRIPTION:The Inaugural ESMO Genitourinary Cancers Asia 2027\, organized by the European Society for Medical Oncology (ESMO)\, will take place on January 15–17\, 2027\, at the Kerry Hotel Hong Kong in Hong Kong SAR\, China. \nThe new congress is dedicated to advancing genitourinary oncology across the Asia-Pacific region\, bringing together regional and international experts for multidisciplinary discussion and presentation of practice-changing research. \nThe scientific programme will cover prostate\, bladder\, kidney\, testicular\, and other genitourinary cancers\, with a focus on clinically relevant evidence\, regional perspectives\, research collaboration\, and innovation in GU cancer care. Abstract submission is open until October 13\, 2026\, and registration is now open\, with the early registration deadline on November 11\, 2026.
URL:https://oncodaily.com/event/esmo-genitourinary-cancers-asia-575063
LOCATION:Kerry Hotel Hong Kong\, 38 Hung Luen Road\, Hung Hom Bay\, Kowloon\, Hong Kong\, Kowloon\, China
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-06_31_15-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270222
DTEND;VALUE=DATE:20270225
DTSTAMP:20260923T123621Z
CREATED:20260923T123544Z
LAST-MODIFIED:20260923T123621Z
UID:10001062-1803254400-1803513599@oncodaily.com
SUMMARY:ESMO Targeted Anticancer Therapies (TAT) Congress 2027
DESCRIPTION:The ESMO Targeted Anticancer Therapies (TAT) Congress 2027 will take place from February 22–24\, 2027\, at the Palais des Congrès de Paris in Paris\, France. \nOrganized by the European Society for Medical Oncology (ESMO)\, the congress will bring together clinicians\, researchers\, and experts in drug development to discuss advances in early-phase oncology research and innovative anticancer therapies. \nThe meeting will focus on the development and clinical translation of targeted anticancer therapies\, including molecularly driven drug development\, precision oncology approaches\, biomarkers\, early clinical trials\, and emerging treatment strategies. The congress provides a platform for researchers\, clinicians\, and industry experts to exchange knowledge on new therapeutic approaches and their path from discovery to patient care.
URL:https://oncodaily.com/event/targeted-anticancer-therapies-591846
LOCATION:Palais des Congrès de Paris\, 2 Pl de la Pte Maillot\, Paris\, Île-de-France\, 75017\, France
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-23-2026-04_34_52-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270304
DTEND;VALUE=DATE:20270307
DTSTAMP:20261031T222338Z
CREATED:20261031T222338Z
LAST-MODIFIED:20261031T222338Z
UID:10001150-1804118400-1804377599@oncodaily.com
SUMMARY:ESMO Sarcoma and Rare Cancers Congress 2027
DESCRIPTION:The ESMO Sarcoma and Rare Cancers Congress 2027\, organized by the European Society for Medical Oncology (ESMO)\, will take place on March 4–6\, 2027\, at Palazzo dei Congressi in Lugano\, Switzerland. \nThe three-day congress will bring together oncologists\, researchers\, pathologists\, surgeons\, and other healthcare professionals to discuss advances in the diagnosis\, molecular classification\, and treatment of sarcomas and rare cancers. The meeting aims to strengthen multidisciplinary collaboration and improve care for patients with rare solid tumours. \nThe scientific programme will feature research presentations\, educational sessions\, multidisciplinary tumour boards\, guideline discussions\, and opportunities for young oncologists. Participants will explore emerging therapeutic approaches\, share clinical experiences\, and discuss challenges in rare cancer research and management.
URL:https://oncodaily.com/event/esmo-622626
LOCATION:Palazzo dei Congressi Lugano\, Piazza dell'Indipendenza 4\, Lugano\, Canton of Ticino\, 6900\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/2027-ESMO-Sarcoma-Congress-Banner.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270308
DTEND;VALUE=DATE:20270311
DTSTAMP:20260822T124507Z
CREATED:20260822T124507Z
LAST-MODIFIED:20260822T124507Z
UID:10000939-1804464000-1804723199@oncodaily.com
SUMMARY:The ESMO Novel Cancer Therapies 2027
DESCRIPTION:The ESMO Novel Cancer Therapies 2027\, organized by the European Society for Medical Oncology (ESMO)\, will take place on March 8–10\, 2027\, in Lugano\, Switzerland. \nThis new ESMO meeting is designed for multidisciplinary oncology professionals and will focus on how approved novel cancer therapies can be translated into everyday clinical practice\, with particular attention to treatment selection\, practical implementation\, toxicity prevention and management\, and optimizing patient outcomes. \nThe programme will combine expert presentations\, multidisciplinary discussions\, real-world clinical cases\, and peer-to-peer learning. Day 1 will feature a major focus on antibody-drug conjugates (ADCs)\, including their clinical use\, supportive care considerations\, management of ADC-related toxicities\, and practical issues around combinations and treatment sequencing. \nAccess the online programme.
URL:https://oncodaily.com/event/esmo-novel-cancer-therapies-572176
LOCATION:Lugano\, Lugano\, Ticino\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/esmo-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270317
DTEND;VALUE=DATE:20270321
DTSTAMP:20260825T230738Z
CREATED:20260825T230738Z
LAST-MODIFIED:20260825T230738Z
UID:10000953-1805241600-1805587199@oncodaily.com
SUMMARY:The European Lung Cancer Congress 2027
DESCRIPTION:The European Lung Cancer Congress 2027 (ELCC 2027) will take place on March 17–20\, 2027\, in Munich\, Germany\, with both onsite and online participation. \nThe congress is jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) and brings together the multidisciplinary thoracic oncology community to advance science\, share education\, and improve clinical practice for patients with lung and other thoracic cancers. \nThe programme is designed for medical oncologists\, radiation oncologists\, thoracic surgeons\, respiratory physicians and pneumologists\, interventional radiologists\, pathologists\, and other professionals involved in thoracic cancer care\, with an emphasis on cross-specialty discussion\, emerging evidence\, and practical take-home insights that can inform everyday patient management.
URL:https://oncodaily.com/event/european-lung-cancer-congress-574706
LOCATION:ICM – International Congress Center Messe München\, Am Messesee 2\, Munich\, Bavaria\, 81829\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-03_05_49-AM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270512
DTEND;VALUE=DATE:20270515
DTSTAMP:20261031T224445Z
CREATED:20261031T224445Z
LAST-MODIFIED:20261031T224445Z
UID:10001152-1810080000-1810339199@oncodaily.com
SUMMARY:ESMO Breast Cancer 2027
DESCRIPTION:The ESMO Breast Cancer 2027 congress\, organized by the European Society for Medical Oncology (ESMO)\, will take place on May 12–14\, 2027\, at Allianz MiCo in Milan\, Italy\, with online participation also available. \nThe international congress will bring together oncologists\, breast cancer specialists\, researchers\, surgeons\, and multidisciplinary healthcare professionals to discuss advances in breast cancer prevention\, diagnosis\, treatment\, and survivorship. The meeting will highlight emerging clinical evidence\, personalized treatment strategies\, and innovations in breast cancer care. \nThe scientific programme will explore developments in systemic and targeted therapies\, precision oncology\, treatment selection and sequencing\, disease monitoring\, and long-term patient outcomes. Through research presentations\, educational sessions\, and expert discussions\, the congress aims to support evidence-based clinical practice and international collaboration in breast oncology.
URL:https://oncodaily.com/event/esmo-622639
LOCATION:Allianz MiCo – South Wing\, Viale Eginardo\, Gate 2\, Milan\, Lombardy\, 20149\, Italy
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/ESMO-Breast-Cancer-Congress-2027.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270618
DTEND;VALUE=DATE:20270621
DTSTAMP:20261101T141746Z
CREATED:20261101T141746Z
LAST-MODIFIED:20261101T141746Z
UID:10001163-1813276800-1813535999@oncodaily.com
SUMMARY:ESMO Targeted Anticancer Therapies Asia Congress 2027
DESCRIPTION:The ESMO Targeted Anticancer Therapies Asia Congress 2027\, organized by the European Society for Medical Oncology (ESMO)\, will take place on June 18–20\, 2027\, at Kerry Hotel in Hong Kong SAR\, China. The international meeting will bring together oncologists\, clinical researchers\, translational scientists and drug development professionals to discuss advances in targeted cancer treatments and early-phase clinical research. \nThe three-day congress will focus on emerging therapeutic targets\, novel anticancer agents and the clinical development of targeted therapies and immunotherapies. It will provide a platform for sharing early clinical research findings and exploring opportunities to advance precision oncology across the Asia-Pacific region. \nThrough scientific presentations\, expert discussions and networking opportunities\, the congress aims to strengthen regional and international collaboration and support the translation of innovative therapeutic approaches into clinical cancer research.
URL:https://oncodaily.com/event/anticancer-therapies-623065
LOCATION:Kerry Hotel\, Hong Kong\, 38 Hung Luen Road\, Hung Hom Bay\, Kowloon\, China
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/11/ESMO-TAT-Asia-Hong-Kong-2027.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270704
DTSTAMP:20261031T234054Z
CREATED:20261031T234054Z
LAST-MODIFIED:20261031T234054Z
UID:10001157-1814313600-1814659199@oncodaily.com
SUMMARY:ESMO Gastrointestinal Cancers Congress 2027
DESCRIPTION:The ESMO Gastrointestinal Cancers Congress 2027\, organized by the European Society for Medical Oncology (ESMO)\, will take place from June 30 to July 3\, 2027\, at the Centre de Convencions Internacional de Barcelona (CCIB) in Barcelona\, Spain\, with online participation also available. \nThe four-day international congress will bring together medical oncologists\, surgeons\, gastroenterologists\, radiation oncologists\, researchers and other healthcare professionals to explore advances in gastrointestinal cancer prevention\, diagnosis and treatment. The meeting will address colorectal\, gastric\, oesophageal\, pancreatic\, hepatobiliary and other gastrointestinal malignancies. \nThe scientific programme will feature research presentations\, multidisciplinary tumour boards\, educational sessions and expert discussions covering emerging therapies\, molecular biomarkers\, precision medicine and evolving treatment strategies. The congress aims to encourage international collaboration and support improvements in clinical practice and patient care.
URL:https://oncodaily.com/event/esmo-622700
LOCATION:Centre de Convencions Internacional de Barcelona (CCIB)\, Plaça de Willy Brandt\, 11–14\, Barcelona\, Catalonia\, 08019\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/2027-ESMO-GI-Congress-Barcelona.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270917
DTEND;VALUE=DATE:20270922
DTSTAMP:20251127T194628Z
CREATED:20251127T194612Z
LAST-MODIFIED:20251127T194628Z
UID:10000413-1821139200-1821571199@oncodaily.com
SUMMARY:ESMO Congress 2027
DESCRIPTION:The ESMO Congress 2027 will take place in Barcelona\, Spain\, from September 17–21\, 2027. \nThis event is recognized as a leading global oncology meeting that serves as a platform for progress by showcasing the latest breakthroughs in oncology research\, clinical practice\, and patient care. The congress brings together a diverse community\, including clinicians\, researchers\, patient advocates\, journalists\, and healthcare industry representatives. \nParticipants can anticipate a dynamic program featuring: \n\nImpactful new data from oncology research.\nInteractive educational sessions.\nUnique networking opportunities.\nA dynamic exhibition area.\n\nBy attending\, participants will gain first-hand insights into the most recent advances and contribute to shaping the future of oncology worldwide.
URL:https://oncodaily.com/event/esmo-congress-2027-417485
LOCATION:Barcelona\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/16_9-1-2.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR